NCT07214896

Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

HEALTH: Humanoid Evaluation and Learning Trial in Coalition-Aligned Healthcare Settings

• Status: Enrolling By Invitation
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: Truway Health, Inc. · Industry
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.

Detailed description

The HEALTH trial (Humanoid Evaluation and Learning Trial in Healthcare) is a coalition-aligned clinical study designed to assess the deployment of humanoid robotics in real-world care environments. Conducted across metro facilities in New York, Austin, Frankfurt, and Tokyo, the trial evaluates robotic performance in patient intake, sanitation, mobility assistance, and ESG-linked operations. Humanoid units are enhanced through biotech integration, including skin cell regeneration dips and stem cell neural augmentation. Each unit is tracked via biometric audit scoring across five dimensions: motor function, cognitive response, ESG compliance, biotech retention, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Wage tokens (HumanoidWage, HMW) are minted based on performance thresholds and distributed through smart contracts to deployed units. FX arbitrage across Tokyo and Frankfurt informs reinvestment logic and 1031 exchange-backed yield farming pools. DAO voting governs deployment, wage calibration, and protocol expansion. This trial aims to establish scalable, transparent frameworks for humanoid integration in healthcare, anchored in coalition governance, public oversight, and metro-ready infrastructure.

Conditions

• Mobility Impairment
• Clinical Workflow Optimization
• Sanitation Protocol Compliance
• ESG-linked Healthcare Robotics Deployment

Interventions

Type	Name	Description
BIOLOGICAL	Skin Cell Dip	Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration.
BIOLOGICAL	Stem Cell Dip	iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning.
OTHER	Wage Token Distribution	HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion.
BEHAVIORAL	ESG Compliance Monitoring, Operational protocol	Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard.

Timeline

• Start date: 2025-10-06
• Primary completion: 2031-10-06
• Completion: 2031-10-06
• First posted: 2025-10-09
• Last updated: 2025-10-20

Locations

4 sites across 3 countries: United States, Germany, Japan

Regulatory

• FDA-regulated drug study